PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target

Abstract Aberrant overexpression or activation of EGFR drives the development of non-small cell lung cancer (NSCLC) and acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) by secondary EGFR mutations or c-MET amplification/activation remains as a major hurdle for NSCLC treatment. We previo...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Shaifali Singh, Nai Yang Yeat, Ya-Ting Wang, Shu-Yu Lin, I-Ying Kuo, Kuen-Phon Wu, Won-Jing Wang, Wen-Ching Wang, Wu-Chou Su, Yi-Ching Wang, Ruey-Hwa Chen
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Publishing Group 2023-10-01
Serie:	Cell Death and Disease
Accesso online:	https://doi.org/10.1038/s41419-023-06201-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!